DRKS00016919
Completed
Not Applicable
DR-brachytherapy with I-125-seeds for prostate cancer - Offenburg results: a retrospective analysis of 260 patients - LDR-BT-OG
Ortenau Klinikum Offenburg-Kehl, Standort St. Josefsklinik0 sites260 target enrollmentApril 11, 2019
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C61
- Sponsor
- Ortenau Klinikum Offenburg-Kehl, Standort St. Josefsklinik
- Enrollment
- 260
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •RETROSPECTIVE: LDR\-brachytherapy (Low dose rate) for prostate cancer in Offenburg in the time from 2002 to 2017
Exclusion Criteria
- •treatment after 09/2015
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 3
SHIP0804JPRN-jRCTs031180256Egawa Shin420
Completed
Phase 3
RCT of Tri-Modalities with I-125 Brachy Therapy and EBRT and Short or Long Term Hormone Therapy for High-risk Localized Prostate CancerProstate CancerJPRN-UMIN000003992Kanazawa University Translational Research Informatices Center340
Completed
Phase 1
Brachytherapy using linked-seed for prostate cancer with one intermediate risk factor -multicenter phase I/II trialJPRN-UMIN000011500Osaka University Graduate School of Medicine, Radiation Oncology25
Recruiting
Not Applicable
Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsyJPRN-UMIN000044790ara Medical University35
Completed
Not Applicable
Dutasteride for biopsy-negative benign prostate hyperplasia - effects on cancer detection and aging male symptomsbiopsy-negative benign prostate hyperplasiaJPRN-UMIN000005288Department of Urology, University of Tokyo Hospital40